Treatment of Anxiety for Children and Adolescents with Inflammatory Bowel Disease
ID Number 09-0268Principal Investigator(s)
Keith J. Benkov
Department(s) or Division(s)
Inflammatory bowel disease (IBD) is a chronic illness with pediatric onset, characterized by potentially disabling symptoms. Due to high morbidity and unpredictable, sometimes embarrassing symptoms, IBD can be particularly distressing during adolescence, a critical period for social, cognitive, and psychosocial development. Elevated rates of psychiatric symptoms, mostly anxiety and depression, have been reported among youth diagnosed with IBD. Of particular concern is that having anxiety in childhood with a chronic illness is linked to poorer quality of life, inappropriate disease management, adverse medical outcomes, symptom exacerbation, and excessive medical service usage. Thus, detection and intervention of emotional distress take on special significance. Our goal is to compare the efficacy of a cognitive-behavioral intervention with a nondirective supportive treatment approach for anxious youth with IBD. The study will assess changes in anxiety symptom severity and IBD symptoms, as well as quality of life, medical management, health service utilization, and school and general functioning.
(718) 951-5000 (ext. 6021)
Recruiting Patients: Yes